跳至主要内容
临床试验/CTRI/2022/07/044092
CTRI/2022/07/044092尚未招募2 期

A randomised controlled trial to evaluate the efficacy of Hinguwadi gutika and Rajahpravartini vati in the Management of Udavarta Yonivyapad W.S.R. to Primary Dysmenorrhea.

ATIONAL INSTITUTE OF AYURVEDA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. PATIENTS WITH CHIEF COMPLAINT OF PAIN DURING MENSES ALONG WITH ASSOCIATED SYMPTOMS.
  • 2. PATIENTS WHO HAVE MENSTRUAL PAIN SCORE MORE THAN GRADE I ACCORDING TO VERBAL MULTIDIMENSIONAL SCORING SYSTEM (VMSS).
  • 3. PATIENTS WHO HAD REGULAR MENSTRAL CYCLES OF 23-35 DAYS IN THE LAST 3 MONTHS.
  • 4. PATIENT IN AGE GROUP OF 18 TO 30 YEARS
  • 5. PATIENTS WITH H/O USING ANALGESICS DURING MENSES.
  • 6. PATIENT WILLING TO GIVE VOLUNTARY INFORMED CONSENT FOR THE STUDY.

排除标准

  • The patient suffering from any severe systemic, or autoimmune disorders, specially those who are mentioned as Asadhya vyadhi as per clinical text of Ayurveda will be excluded.
  • Subjects having organic pathology of uterus and adnexa like Fibroid uterus,carcinoma of endometrium, endometriosis etc.
  • 1having pelvic inflammatory disease or 2chronic leucorrhoea.
  • 3Patients who vaccinated for covid19 with in past three month.

研究者

相似试验